Canine osteoarthritis is a common chronic degenerative joint condition that affects the whole joint but the most prominent symptom is the loss of articulate cartilage. OA causes pain, lameness, decreased mobility, and if not managed on time and correctly the symptoms will escalate to muscular atrophy, joint effusion, incorrect joint articulation, etc. Dogs that experience …
Our team have recently moved to our brand-new R&D facilities in Szeged. The new GMP cell-production facility will fuel our growth and allow us to create a pipeline for developing more innovative treatments in the near future. Importantly, our facilities now contain all necessary suits for handling and preparation of stem cell products that meet …
managing arthritis and injury by stem cells in zoo animals Wild animals that are bred in captivity are often a core part of projects that aim to restore wild populations of that might otherwise go extinct. Thus, it is important to ensure the best quality of life of captive animals, both for welfare reasons, as …
managing arthritis and injury by stem cells in zoo animals Read More »
According to recent studies from our own research group as well as others, mesenchymal stem cells can be used for various purposes from aiding in wound healing to restoring crucial organ functions (pancreatic islet cells for diabetes patients). A possibility to treat orthopaedic disorders by stem cell therapy has received a lot of attention in …
Use of mesenchymal stem cells (MSCs) in regenerative medicine Read More »
The human body is made up from a large number of different cell types, many of which have specific functions, for example, blood cells, muscle cells, nerve cells, bone cells, fat cells etc. Although the structures or organs they make up seem to have permanence, many of the cells have a limited lifetime within the …
Our new Production and R&D site in Szeged, Hungary is nearing completion. We are delighted to share that our brand-new facility will soon be up and running. Occupying 1000 square metres in the new state of the art development, the purpose-built GMP production facility and quality control laboratories will be used to produce at scale …
Our New State of the Art production and R&D site Read More »
Stem CellX recently presented at the Budapest Zoo about treating Osteoarthritis in dogs, using mesenchymal stem cells with a discussion about the possibilities this novel regenerative medicine approach for zoo animals
StemCellX will soon have a new R&D and a GMP Production Site: We will occupy over 1000 square metres within this new, state-of-the-art laboratory building, scheduled to be completed by Q3 2022. Our facility will accommodate advanced GMP manufacturing suites for large-scale, commercial production of our stem cell-based products, as well as R&D laboratories. We have …
StemCellX Breaks ground on a new R&D and a GMP Stem Cell Production Site Read More »
Our most recent article “A Regenerative Approach to Canine Osteoarthritis Using Allogeneic, Adipose-Derived Mesenchymal Stem Cells. Safety Results of a Long-Term Follow-Up” has been published in the Frontiers in Veterinary Science journal. In this study we aimed to further explore the safety and effectiveness of allogeneic mesenchymal stem cells for the treatment of joint degenerative …
a long-term follow up of our stem cell treatment in Frontiers in Veterinary Science Read More »
Our article “Characterisation and therapeutic application of canine adipose mesenchymal stem cells to treat elbow osteoarthritis” has been published in the CJVR. By using cytofluorometry we were able to determine the optimal method of culturing allogeneic (coming from a healthy donor) mesenchymal stem cells obtained from adipose tissue to prepare an injectable formulation for treating …
